The Scoop
Epoch Biodesign, a London-based company developing enzymatic recycling technology, closed a $12M strategic funding round. Lululemon, KOMPAS VC, Happiness Capital, Extantia, and Leitmotif participated. March 2026. Total funding exceeds $50M.
The Context
Epoch Biodesign focuses on circularity, enabling nylon 6,6 recycling without virgin feedstock. Their enzymatic process breaks down waste garments into chemical components for new polymers and yarn. This addresses a significant environmental challenge in the textile industry, heavily reliant on non-sustainable materials. The funding highlights increasing investor interest in circular economy solutions. Their technology aims to process complex materials, including blended textiles and mixed plastics, often difficult to recycle.